| __timestamp | Amneal Pharmaceuticals, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 84580000 |
| Thursday, January 1, 2015 | 136870000 | 86943000 |
| Friday, January 1, 2016 | 204747000 | 84493000 |
| Sunday, January 1, 2017 | 191938000 | 64988000 |
| Monday, January 1, 2018 | 210451000 | 74951000 |
| Tuesday, January 1, 2019 | 202287000 | 62331000 |
| Wednesday, January 1, 2020 | 190585000 | 28607000 |
| Friday, January 1, 2021 | 209563000 | 32228000 |
| Saturday, January 1, 2022 | 200046000 | 46600000 |
| Sunday, January 1, 2023 | 167778000 | 54886000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation, two prominent players in the industry, have shown distinct trends in their R&D investments over the past decade.
From 2014 to 2023, Amneal Pharmaceuticals consistently allocated a significant portion of its budget to R&D, peaking in 2018 with a 97% increase from 2014. However, a notable decline of 20% was observed by 2023. In contrast, Dynavax Technologies experienced a more volatile R&D expenditure pattern, with a sharp 66% drop from 2016 to 2020, followed by a gradual recovery.
These trends highlight the strategic differences in how these companies prioritize innovation, reflecting their unique approaches to navigating the ever-evolving pharmaceutical landscape.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Dynavax Technologies Corporation
Pfizer Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Dynavax Technologies Corporation
R&D Spending Showdown: argenx SE vs Dynavax Technologies Corporation
BeiGene, Ltd. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Dynavax Technologies Corporation
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Pharming Group N.V. vs Dynavax Technologies Corporation
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.